Schaur R J, Semmelrock H J, Schreibmayer W, Tillian H M, Schauenstein E
J Cancer Res Clin Oncol. 1980;97(3):285-93. doi: 10.1007/BF00405780.
The continuous administration of physiological doses of the branched-chain amino acids leucine, isoleucine, and valine (Leu-Ile-Val) to Yoshida sarcoma-bearing rats caused a significant increase in the survival time by 32% and a significant reduction of tumor size after 3 weeks of growth by 33%. The shift of the nitrogen balance to negative values during the cachectic stage was delayed but not prevented. On the average, less nitrogen (-47 mg/day) were lost by Leu-Ile-Val treated rats compared with untreated tumor-bearing animals (-91 mg N/day). It appeared that Leu-Ile-Val increased the synthesis of carcass proteins, while it left the proteolysis rate unchanged, since the excretion of urea and creatinine was unaffected by these amino acids. The daily excretion of alpha-ketoglutarate, which is correlated with tumor size during the early stage of growth, was decreased during the first 2 weeks by Leu-Ile-Val, but remained for a longer period on a high level than in untreated tumor bearers. The results point to an improvement of the metabolic resistance against carcass protein depletion of the tumor-bearing host by the administration of branched-chain amino acids.
给患吉田肉瘤的大鼠持续给予生理剂量的支链氨基酸亮氨酸、异亮氨酸和缬氨酸(Leu-Ile-Val),可使存活时间显著延长32%,并使肿瘤生长3周后的大小显著减小33%。恶病质阶段氮平衡向负值的转变有所延迟,但未能阻止。平均而言,与未治疗的荷瘤动物(-91毫克氮/天)相比,Leu-Ile-Val治疗的大鼠损失的氮较少(-47毫克/天)。似乎Leu-Ile-Val增加了机体蛋白质的合成,而蛋白水解率保持不变,因为这些氨基酸对尿素和肌酐的排泄没有影响。在生长早期与肿瘤大小相关的α-酮戊二酸的每日排泄量,在最初2周内被Leu-Ile-Val降低,但在高水平维持的时间比未治疗的荷瘤动物更长。结果表明,给予支链氨基酸可改善荷瘤宿主对机体蛋白质消耗的代谢抗性。